Navigation Links
New Vascular Access Medical Devices Launched by Navilyst Medical
Date:9/11/2008

Navilyst Medical, the manufacturer and global marketer of vascular access and fluid management medical devices, has launched new products just four weeks after the company's introduction of its new corporate brand following the previously announced divestiture from Boston Scientific. They are: 1) an Expanded PICC Convenience Kit program , 2) the inudstry's only dual-safety EZ Huber® Infusion Needle Set; and 3) new Xcela® Power Injectable Ports. The two new devices and enhanced PICC Convenience Kitting offerings expand Navilyst Medical's popular vascular access device product lines and can contribute to a hospital's infection prevention program. The products are designed to contribute to a hospital's compliance with OSHA regulations, CDC guidelines, as well as recently announced Joint Commission Hospital Patient Safety Goals.

Marlborough, MA (PRWEB) September 11, 2008 -- Navilyst Medical, the manufacturer and global marketer of vascular access and fluid management medical devices, today announced its first in a series of new product launches as the company's newly branded entity. These new products are being debuted just four weeks after the company's introduction of its new corporate brand, following the previously announced divestiture from Boston Scientific. The products are designed to contribute to a hospital's compliance with OSHA regulations, CDC guidelines, as well as recently announced Joint Commission Hospital Patient Safety Goals.

The two new devices and enhanced PICC Convenience Kitting offerings expand Navilyst Medical's popular vascular access device product lines and can contribute to a hospital's infection prevention program. The new products will be premiered at Booth #202 at Annual Scientific Meeting of the Association for Vascular Access (AVA) in Savannah, Georgia this week.
http://www.navilystmedical.com/press [These Navilyst Medical device images are available for download.]

More Customized PICC Convenience Kits:
Navilyst Medical's market-leading offering of customized PICC kits manufactured by Navilyst Medical's Glens Falls, NY facility has been expanded. These enhancements include the new Xcela® Power Injectable PICC and a wider array of PICC insertion accessories and packaging. The market focus for the PICC Convenience Kitting program is on the bedside placement segment which accounts for over two-thirds of the approximately two million Peripherally Inserted Central Catheters (PICCs) that are sold in the U.S. annually. The program provides clinicians and hospitals the catheter and accessory choices they require for a procedure that is efficient and conducive to reducing the risk of accidental needlesticks (OSHA) and infections (CDC and Joint Commission). This also reduces costs from unnecessary supplies. These PICC Convenience Kits can be ordered with Navilyst Medical's proprietary PASV® valve catheters which are proven to reduce rates of catheter occlusions and infections--- another asset as hospitals prepare for the upcoming reimbursement restrictions by Centers for Medicare and Medicaid Services (CMS) for preventable complications which include catheter-related bloodstream infections.

New Xcela® Power Injectable Ports:
Port catheter systems are implanted in over 300,000 patients annually in the U.S. to provide a means for long-term delivery of fluids and medications including chemotherapy. For those who value the benefits of power injectability, Navilyst Medical's new Xcela Power Injectable Port s will offer the widest array of port options to satisfy the demands of physician preferences and patient characteristics. The titanium Xcela ports, available in standard and low profile sizes, offer durability and reduced size for ease of implantation and patient comfort. The plastic Xcela ports are light weight for patient comfort and offer radiolucence-reduced imaging artifact. Finally, the plastic/titanium hybrid port design option combines the durability of titanium with the light weight and radiolucence of plastic. All designs have a 5mL/sec with 300 psi infusion rating for use in contrast-enhanced imaging procedures. Xcela ports are compatible with the Company's new EZ Huber® safety Infusion Set.

New EZ Huber® Safety Infusion Set:
Navilyst Medical's new EZ Huber® Safety Infusion Set has a unique dual-action safety mechanism designed to reduce the risk of bloodborne pathogen exposure that threatens clinician safety and is a significant cost to the healthcare system. One safety feature shields the tip of the needle after the needle is withdrawn from the patient to prevent accidental needle sticks. The second safety feature is a protective cover that surrounds the entire needle after withdrawal to reduce exposure to aerosolized or splattered infusion fluids and blood. The EZ Huber® Safety Infusion Set is compatible with Navilyst Medical's new Xcela® Power Injectable Port and is rated for up to 5mL/sec at 300 psi for contrast-enhanced CT imaging procedures. Approximately 10 million Huber needle infusion sets are used annually in the U.S. to provide access to implanted port catheters.
Dave McClellan said today's announcement reflects Navilyst Medical's plans to be an aggressive device innovator. "These products that focus on both clinician and patient reflect our pledge to collaborate with our healthcare customers to deliver the technology and support they most need for efficient, safe, and effective interventional procedures They also met our pledge to do so with urgency while upholding the highest standards of quality, "said McClellan. "Our customers are excited---and they know there is more to follow."

About Navilyst Medical
Navilyst Medical, headquartered in Marlborough, MA, was formed in February 2008 from Boston Scientific's Fluid Management and Vascular Access business units. Its breakthrough devices, including the PASV® Valve Technology, expanded line of Xcela® PICCs and world-leading NAMIC® Fluid Management products, help hospitals to achieve safe, favorable outcomes for patients. The Company distributes its products worldwide and has its lead U.S. manufacturing facility in Glens Falls, NY. The name Navilyst combines the navi-- of navigation and the --lyst of catalyst, encompassing how a leading medical technology enterprise drives industry-changing innovation. For more information, please visit: www.navilystmedical.com. EZ Huber® is a registered trademark of Kerr Marketing, Inc.

FORWARD-LOOKING STATEMENTS: This Release contains forward-looking statements, including statements regarding development of Navilyst Medical's existing and new products, the Company's progress toward commercial growth, and future opportunities. The Company's actual results may differ materially from those anticipated in these forward-looking statements based upon a number of factors, including uncertainties associated with development, testing and related regulatory approvals, anticipated future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological change, government regulation, future capital needs and uncertainty of additional financing, and other risks and challenges. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this Release. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this Release or to reflect the occurrence of unanticipated events.

###

Read the full story at http://www.prweb.com/releases/2008/09/prweb1317104.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MAQUET Cardiovascular Responds to Terumo Complaint About VASOVIEW Endoscopic Vessel Harvesting Systems
2. Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke
3. Journal of Cardiovascular Electrophysiology Publishes Data Showing Ranolazine Shortened QT Interval and Improved Cardiac Relaxation in Study of Patients With Long QT Syndrome
4. Navilyst Medical Announces Global Debut Today : Former Boston Scientific Business Units Combine to Lead Fluid Management and Vascular Access Markets
5. New discovery may lead to immunization against cardiovascular disease
6. Geneva Offers First Cardiovascular Technology Graduate Program in the Nation
7. Insight into mechanisms of diabetes-induced microvascular disease reveals new therapies
8. Vascular Solutions CEO Elected to MDMA Board of Directors
9. Leading worldwide cause of cardiovascular disease may be modified by diet
10. The Foundation for Accelerated Vascular Research Grants $150,000 Wylie Scholar Award for Blood Vessel Research
11. Building a Fully Integrated Cardiovascular Imaging and Information System Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Vascular Access Medical Devices Launched by Navilyst Medical
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: